1. Home
  2. GLAD vs DNA Comparison

GLAD vs DNA Comparison

Compare GLAD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • DNA
  • Stock Information
  • Founded
  • GLAD 2001
  • DNA 2008
  • Country
  • GLAD United States
  • DNA United States
  • Employees
  • GLAD N/A
  • DNA N/A
  • Industry
  • GLAD Finance/Investors Services
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GLAD Finance
  • DNA Health Care
  • Exchange
  • GLAD Nasdaq
  • DNA Nasdaq
  • Market Cap
  • GLAD 571.4M
  • DNA 466.4M
  • IPO Year
  • GLAD N/A
  • DNA N/A
  • Fundamental
  • Price
  • GLAD $26.95
  • DNA $11.42
  • Analyst Decision
  • GLAD Hold
  • DNA Sell
  • Analyst Count
  • GLAD 1
  • DNA 3
  • Target Price
  • GLAD $23.00
  • DNA $9.67
  • AVG Volume (30 Days)
  • GLAD 75.0K
  • DNA 1.4M
  • Earning Date
  • GLAD 08-06-2025
  • DNA 08-07-2025
  • Dividend Yield
  • GLAD 7.33%
  • DNA N/A
  • EPS Growth
  • GLAD 17.67
  • DNA N/A
  • EPS
  • GLAD 3.93
  • DNA N/A
  • Revenue
  • GLAD $92,932,000.00
  • DNA $237,417,000.00
  • Revenue This Year
  • GLAD N/A
  • DNA N/A
  • Revenue Next Year
  • GLAD $12.10
  • DNA $15.81
  • P/E Ratio
  • GLAD $6.88
  • DNA N/A
  • Revenue Growth
  • GLAD N/A
  • DNA 13.76
  • 52 Week Low
  • GLAD $21.40
  • DNA $5.00
  • 52 Week High
  • GLAD $30.43
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 53.98
  • DNA 64.12
  • Support Level
  • GLAD $25.82
  • DNA $8.21
  • Resistance Level
  • GLAD $26.81
  • DNA $10.02
  • Average True Range (ATR)
  • GLAD 0.49
  • DNA 0.69
  • MACD
  • GLAD -0.06
  • DNA 0.09
  • Stochastic Oscillator
  • GLAD 53.34
  • DNA 84.19

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: